Variant report
Variant | nsv828877 |
---|---|
Chromosome Location | chr21:41118265-41118835 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:41118789..41121502-chr21:41136765..41138744,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
IGSF5 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577533453 | chr21:41118265-41118266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs570473630 | chr21:41118291-41118292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs537898792 | chr21:41118320-41118321 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540246392 | chr21:41118336-41118337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs61040557 | chr21:41118345-41118346 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs1735142 | chr21:41118353-41118354 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs375789497 | chr21:41118388-41118389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs412661 | chr21:41118427-41118428 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs181560000 | chr21:41118441-41118442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs572336312 | chr21:41118446-41118447 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185824259 | chr21:41118453-41118454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs117088958 | chr21:41118458-41118459 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs75698636 | chr21:41118512-41118513 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190147139 | chr21:41118516-41118517 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs1735143 | chr21:41118517-41118518 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs182363876 | chr21:41118538-41118539 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1235466 | chr21:41118552-41118553 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs146574810 | chr21:41118598-41118599 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201830314 | chr21:41118601-41118602 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs386818581 | chr21:41118608-41118609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs72380531 | chr21:41118610-41118611 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs60227846 | chr21:41118612-41118613 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs535985618 | chr21:41118613-41118614 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs1235467 | chr21:41118615-41118616 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs549144597 | chr21:41118622-41118623 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1235468 | chr21:41118630-41118631 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs116797450 | chr21:41118633-41118634 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs558003202 | chr21:41118655-41118656 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs62235514 | chr21:41118665-41118666 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs574470134 | chr21:41118666-41118667 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs116613333 | chr21:41118675-41118676 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs150770765 | chr21:41118678-41118679 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374533912 | chr21:41118694-41118695 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs200789683 | chr21:41118715-41118716 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs2837148 | chr21:41118783-41118784 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs413515 | chr21:41118812-41118813 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs562654832 | chr21:41118834-41118835 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Mental retardation | 21031080 | CNVD |
Polymicrogyria | 21031080 | CNVD |
periventricular nodular heterotopia | 21031080 | CNVD |
Myelodysplastic syndrome | 21606161 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Autism | 18414403 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21858162 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17899364 | CNVD |
Down syndrome | 20877625 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Prostate cancer | 21147910 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 20473283 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 22522925 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:41104200-41138400 | Weak transcription | Pancreas | Pancrea |
2 | chr21:41107800-41119400 | Enhancers | Placenta | Placenta |
3 | chr21:41110000-41148400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr21:41115600-41122000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |